Soricimed Publishes New Research Validating TRPV6 as a Therapeutic Target for Ovarian Cancer
October 31, 2018 15:00 ET
|
Soricimed Biopharma Inc.
MONCTON, New Brunswick, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing targeted cancer therapeutics, is...
Soricimed Announces Changes to its Board of Directors
September 04, 2018 07:00 ET
|
Soricimed Biopharma Inc.
MONCTON, New Brunswick, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing targeted cancer therapeutics, is...
Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Directors
March 19, 2018 14:30 ET
|
Soricimed Biopharma Inc.
MONCTON, New Brunswick, March 19, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing targeted cancer therapeutics, is...